BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8309616)

  • 1. Chronic morphine alters dopamine transporter density in the rat brain: possible role in the mechanism of drug addiction.
    Simantov R
    Neurosci Lett; 1993 Dec; 163(2):121-4. PubMed ID: 8309616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: binding to dopamine transporters?
    Sharif NA; Nunes JL; Kalfayan V; McClelland DL; Rosenkranz RP; Eglen RM; Whiting RL
    Neurochem Int; 1992 Jul; 21(1):69-73. PubMed ID: 1303143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the characteristics of dopamine transporter in brain regions and spinal cord of morphine tolerant and abstinent rats.
    Gudehithlu KP; Bhargava HN
    Neuropharmacology; 1996 Feb; 35(2):169-74. PubMed ID: 8734485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing effects of clomipramine on [125I]RTI-55 and [3H]N-methylspiperone binding in mouse striatum: important role of other factors than endogenous dopamine?
    Inoue O; Kobayashi K; Hosoi R; Gee A
    Synapse; 1998 Nov; 30(3):338-40. PubMed ID: 9776138
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration.
    Wilson JM; Nobrega JN; Carroll ME; Niznik HB; Shannak K; Lac ST; Pristupa ZB; Dixon LM; Kish SJ
    J Neurosci; 1994 May; 14(5 Pt 2):2966-79. PubMed ID: 8182452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
    J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain.
    Boja JW; Mitchell WM; Patel A; Kopajtic TA; Carroll FI; Lewin AH; Abraham P; Kuhar MJ
    Synapse; 1992 Sep; 12(1):27-36. PubMed ID: 1411961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum.
    Naudon L; Leroux-Nicollet I; Boulay D; Costentin J
    J Neural Transm (Vienna); 2001; 108(4):431-44. PubMed ID: 11475010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and binding properties of [3H]NNC 12-0781, a new radioligand for the dopamine reuptake system.
    Müller L; Hall H; Halldin C; Farde L; Hohlweg R; Suzdak PD; Nielsen EB; Foged C
    Nucl Med Biol; 1995 Aug; 22(6):711-7. PubMed ID: 8535331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
    Moll GH; Mehnert C; Wicker M; Bock N; Rothenberger A; Rüther E; Huether G
    Brain Res Dev Brain Res; 2000 Feb; 119(2):251-7. PubMed ID: 10675775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide interacts with the dopamine transporter in rat brain synaptosomes.
    Campbell AD; Womer DE; Simon JR
    Eur J Pharmacol; 1995 Jul; 290(2):157-62. PubMed ID: 8575531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microheterogeneity of dopamine transporters in rat striatum and nucleus accumbens.
    Lew R; Patel A; Vaughan RA; Wilson A; Kuhar MJ
    Brain Res; 1992 Jul; 584(1-2):266-71. PubMed ID: 1515945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prenatal methylazoxymethanol treatment on striatal dopaminergic systems in rat brain.
    Watanabe M; Nonaka R; Hagino Y; Kodama Y
    Neurosci Res; 1998 Feb; 30(2):135-44. PubMed ID: 9579647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic blockade of opioid receptors alters the binding of [3H]GBR 12935 to dopamine transporter in rat brain regions and spinal cord.
    Bhargava HN; Gudehithlu KP
    Pharmacology; 1996 Apr; 52(4):243-51. PubMed ID: 8841087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine transporter binding in rat striatum and nucleus accumbens is unaltered following chronic changes in dopamine levels.
    Moody CA; Granneman JG; Bannon MJ
    Neurosci Lett; 1996 Oct; 217(1):55-7. PubMed ID: 8905738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    Wall SC; Innis RB; Rudnick G
    Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects.
    Belej T; Manji D; Sioutis S; Barros HM; Nobrega JN
    Brain Res; 1996 Oct; 736(1-2):287-96. PubMed ID: 8930335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
    Niznik HB; Tyndale RF; Sallee FR; Gonzalez FJ; Hardwick JP; Inaba T; Kalow W
    Arch Biochem Biophys; 1990 Feb; 276(2):424-32. PubMed ID: 2306106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine acutely and persistently attenuates nonvesicular GABA release in rat nucleus accumbens.
    Schoffelmeer AN; Wardeh G; Vanderschuren LJ
    Synapse; 2001 Nov; 42(2):87-94. PubMed ID: 11574945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
    Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM
    Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.